86 related articles for article (PubMed ID: 4309848)
1. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
[No Abstract] [Full Text] [Related]
2. Antiviral activity of 9-beta-D-arabinofuranosyladenine. VI. Effect of delayed treatment on herpes simplex virus in mice.
Miller FA; Sloan BJ; Silverman CA
Antimicrob Agents Chemother (Bethesda); 1969; 9():192-5. PubMed ID: 5396486
[No Abstract] [Full Text] [Related]
3. Antiviral activity of 9-beta-D-arabinofuranosyladenine. 3. Reduction in evidence of encephalitis in treated herpes Simplex-infected hamsters.
Schardein JL; Sidwel RW
Antimicrob Agents Chemother (Bethesda); 1968; 8():155-60. PubMed ID: 4309847
[No Abstract] [Full Text] [Related]
4. Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.
Sidwell RW; Dixon GJ; Schabel FM; Kaump DH
Antimicrob Agents Chemother (Bethesda); 1968; 8():148-54. PubMed ID: 5735359
[No Abstract] [Full Text] [Related]
5. The N6-(dimethylamino)methylene derivative of 9-beta-D-arabinofuranosyladenine as an antiviral agent.
Hanessian S
J Med Chem; 1973 Mar; 16(3):290-2. PubMed ID: 4354694
[No Abstract] [Full Text] [Related]
6. [Effect of desoxyribonuclease on herpes simplex virus].
Kossak NI
Mikrobiol Zh; 1967; 29(4):312-6. PubMed ID: 4310245
[No Abstract] [Full Text] [Related]
7. Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice.
Dixon GJ; Sidwell RW; Miller FA; Sloan BJ
Antimicrob Agents Chemother (Bethesda); 1968; 8():172-9. PubMed ID: 4309849
[No Abstract] [Full Text] [Related]
8. Maternal and neonatal herpes simplex virus infections.
Keller DL
N Engl J Med; 2009 Dec; 361(27):2678-9; author reply 2679. PubMed ID: 20050389
[No Abstract] [Full Text] [Related]
9. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
10. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
[TBL] [Abstract][Full Text] [Related]
11. [Herpetic eye disease caused by herpes simplex virus].
Ben-Simon G; Bareguet I
Harefuah; 2001 Oct; 140(10):959-66. PubMed ID: 11681133
[No Abstract] [Full Text] [Related]
12. Studies on virus-inhibiting substances of bacterial origin. IV. Antiviral substances extractable from Streptococcus faecalis: its in vivo effect.
Fujisaki M; Uchida S; Kojima M; Hotta S; Hamada C; Maeyama Y
Kobe J Med Sci; 1978 Jun; 24(2):115-23. PubMed ID: 101714
[No Abstract] [Full Text] [Related]
13. Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine.
Sloan BJ; Miller FA; McLean IW
Antimicrob Agents Chemother; 1973 Jan; 3(1):74-80. PubMed ID: 4790577
[TBL] [Abstract][Full Text] [Related]
14. Therapy of herpes simplex virus infections: a prospective view.
Schwartz J; Elizan TS
Mt Sinai J Med; 1973; 40(5):641-51. PubMed ID: 4125976
[No Abstract] [Full Text] [Related]
15. [The antiviral activity and therapeutic efficacy of hydrophobized monoclonal antibodies against the herpes simplex virus].
Kolomiets AG; Votiakov VI; Vladyko GV; Ovcharenko AV; Kabanov AV; Melik-Nubarov NS; Iaskovets NIu; Malakhova IV; Eremin VF; Moroz AG
Dokl Akad Nauk SSSR; 1991; 317(6):1487-90. PubMed ID: 1654244
[No Abstract] [Full Text] [Related]
16. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
Enright AM; Prober C
Herpes; 2003 Aug; 10(2):32-7. PubMed ID: 14577952
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
Marks MI
J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
[TBL] [Abstract][Full Text] [Related]
18. Thymine arabinoside (Ara-T) topical and iontophoretic application for herpes simplex virus type 1 and type 2 skin infections in hairless mice.
Hill JM; Wiggins CA; Kwon BS; Gentry GA; Gangarosa LP
Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):17-20. PubMed ID: 6717166
[TBL] [Abstract][Full Text] [Related]
19. New antiviral drugs that target herpesvirus helicase primase enzymes.
Kleymann G
Herpes; 2003 Aug; 10(2):46-52. PubMed ID: 14577954
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
